Error: Could not add to watchlist. X

Summit Therapeutics PLC

+ Watchlist
SUMM:LN
London
133.50
GBp
0.00
0.00%
As of 11:30:00 ET on 06/03/2015.
Open
133.50
Day Range
133.50 - 133.50
Volume
11,708
Previous Close
133.50
52Wk Range
101.25 - 185.00
1 Yr Return
-7.93%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-0.29
Market Cap (m GBp)
81.437
Shares Outstanding (m)
61.002
Price/Sales (TTM)
88.57
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
ADDRESS
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
PHONE
44-123-544-3939
  • Glyn O Edwards
    Chief Executive Officer
  • Erik Ostrowski
    Chief Financial Officer
  • Jonathon Tinsley
    Former Chief Scientific Officer
  • Richard Vickers
    Chief Scientific Officer
  • Bina Tejura
    VP:Clinical Development
Show More